Polvo masculino del aumento de Testolactona para tratar el cáncer de mama 968-93-4

Polvo masculino del aumento de Testolactona para tratar el cáncer de mama 968-93-4

Descripción;

TESLAC is available for oral administration as tablets providing 50 mg testolactone per tablet. Testolactone is a synthetic antineoplastic agent that is structurally distinct from the androgen steroid nucleus in possessing a six-membered lactone ring in place of the usual five-membered carbocyclic D-ring. Testolactone is chemically designated as 13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid δ-lactone.

Testolactone is an antineoplastic that is related to testosterone but has not been shown to have the masculine effects of testosterone. It works by blocking the production of estrogen, which helps prevent the growth of breast cancers that are activated by estrogen. It may also prevent tumor cells from being activated by other hormones.

Aplicaciones;

Testolactone is an antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.Testolactone is a progesterone derivative with antineoplastic activity. Testolactone inhibits steroid aromatase, thereby preventing the formation of estrogen from adrenal androstenedione and reducing endogenous estrogen levels. Teslac is an anticancer rug used to treat some types of breast cancer.

Teslac is neither an anabolic nor an androgenic steroid. It is actually considered a sex hormone that is a relative of testosterone and was developed for women for medical purposes. Teslac is widely used in the steroid community as probably the most effective anti-estrogen. When combined with Proviron, Teslac is almost certain to completely prevent estrogen conversion and it associated problems. Some have said it has even completely and permanently suppressed their estrogen content.